United Therapeutics Corporation (NASDAQ:UTHR) Q4 2025 Earnings Call Transcript February 25, 2026
United Therapeutics Corporation beats earnings expectations. Reported EPS is $7.61, expectations were $6.78.
Operator: Good morning, everyone, and welcome to the United Therapeutics Corporation Fourth Quarter 2025 Corporate Update Conference Call. My name is Jamie, and I will be your conference operator today. [Operator Instructions] Please also note today’s event is being recorded. At this time,...
